Frauke Goeman

Immune checkpoint therapy—current perspectives and future directions

Genome-wide prediction of disease variant effects with a deep protein language model

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth

Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects